Results 21 to 30 of about 66,784,034 (314)
COVID‐19: vaccine’s progress [PDF]
Summary Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out into mass vaccination campaigns at incredible speed. What normally takes a decade was worked out within a year. Vaccines were produced along many different platforms ranging from inactivated whole virus vaccines over adenovirus‐vectored ...
openaire +4 more sources
The Time for COVID-19 Vaccination
The composition and dynamics of viral mutant spectra in infected individuals advise that to avoid selection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape mutants, vaccination campaigns for coronavirus disease 2019 (COVID-19) should be launched when disease incidence is low.
Domingo, Esteban, Perales, Celia
openaire +4 more sources
COVID-19 Vaccine Development to Vaccination
In the race for a safe and effective vaccine against Coronavirus disease-19 manufacturer plays a critical role throughout the development, clinical trial, manufacturing, supply, and vaccination phases. For the efficacy of Coronavirus disease-19 vaccine, proper transport, storage, vaccine carrier, adjuvant, dosage form and route of vaccine ...
Ashok Pandey +2 more
openaire +2 more sources
COVID-19 vaccines for children [PDF]
Earlier this month, the US Centers for Disease Control and Prevention (CDC) recommended Pfizer’s COVID-19 messenger RNA (mRNA) vaccine for children between 5 and 11 years of age—that’s 28 million children. Yet surveys show that 42 to 66% of parents of these children are reluctant or opposed to seeking this protection.
Jeffrey S, Gerber, Paul A, Offit
openaire +2 more sources
Equity in Vaccination: A Plan to Work with Communities of Color Toward COVID-19 Recovery and Beyond [PDF]
The coronavirus disease 2019 (COVID-19) pandemic has had tragic and disproportionate adverse effects on Black, Indigenous, and People of Color (BIPOC) communities across the United States.
Schoch-Spana, Monica
core +1 more source
Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination
The risk of stroke and cerebrovascular disease complicating infection with SARS-CoV-2 has been extensively reported since the onset of the pandemic. The striking efforts of many scientists in cooperation with regulators and governments worldwide have rapidly brought the development of a large landscape of vaccines against SARS-CoV-2.
Manuela De Michele +6 more
openaire +3 more sources
Subacute thyroiditis following COVID‐19 vaccination
Physicians should be alert about the possibility of subacute thyroiditis (SAT) being induced by COVID‐19 vaccination. SAT may present with anterior neck pain, extended fever or palpitation in recently vaccinated patients, which should not be easily ...
Pardis Soltanpoor, Ghazal Norouzi
doaj +1 more source
The present study aimed (1) to identify distinct latent classes of motivation to get vaccinated against coronavirus disease 2019 (COVID-19) and previous seasonal influenza vaccination among people in Taiwan and (2) to examine the roles of sources of ...
Yi-Lung Chen +4 more
doaj +1 more source
COVID-19 Vaccination among Czech Dentists
This work describes and evaluates vaccination against COVID-19 among members of the Czech Dental Chamber during the pre-booster vaccination phase. A cross-sectional online survey was conducted between 23 June and 4 September 2021, among 2716 participants,
Vojtech Perina +5 more
core +1 more source
Hearing Loss after COVID-19 and Non-COVID-19 Vaccination: A Systematic Review
(1) Background: Vaccine safety is an important topic with public health implications on a global scale. The purpose of this study was to systematically review available literature assessing sensorineural hearing loss (SNHL) incidence and severity ...
Yan Qing Cherie Ong +3 more
core +1 more source

